Pneumococcal and influenza vaccination status of hospitalized adults with community acquired pneumonia and the effects of vaccination on clinical presentation
Background: Previous reports have shown that vaccination rates of adult at-risk populations are low in Turkey. There are differing reports with regards to the effectiveness of the influenza and the pneumococcal polysaccharide vaccine (PPSV23) on the clinical outcomes of community acquired pneumonia...
Saved in:
Main Authors: | Ezgi Demirdogen Cetinoglu (Author), Esra Uzaslan (Author), Abdullah Sayıner (Author), Aykut Cilli (Author), Oguz Kılınc (Author), Aysın Sakar Coskun (Author), Armağan Hazar (Author), Nurdan Kokturk (Author), Ayten Filiz (Author), Mehmet Polatli (Author), on behalf of TURCAP Study Group (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nasopharyngeal pneumococcal carriage in healthy Turkish children after 13-valent conjugated pneumococcal vaccine implementation in the national immunization program
by: Saliha Kanık Yüksek, et al.
Published: (2020) -
PNEUMOCOCCAL INFECTION VACCINAL PREVENTION EFFICACY IN CHILDREN USING PNEUMOCOCCAL CONJUGATED 7-VALENT VACCINE
by: N. L. Chernaya, et al.
Published: (2013) -
State of pneumococcal vaccine immunity
by: Mustafa Akkoyunlu
Published: (2024) -
Cost-effectiveness of the 13-valent pneumococcal conjugate vaccine in adults in Portugal versus "no vaccination" and versus vaccination with the 23-valent pneumococcal polysaccharide vaccine
by: Miguel Gouveia, et al.
Published: (2019) -
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
by: James T. Peterson, et al.
Published: (2019)